Exciting news from Lenox Hill Neurosurgery as John Boockvar, Yafell Serulle, MD, PhD, and @weinjc have begun enrolling and treating patients in the #FRONTIERstudy assessing the use #TheraSphereGBM #Y90 in pts with recurrent #GBM . TY to the entire team at Lenox Hill Hospital and Northwell Health
Today is #GBMDay . Proud to help shine a light on the most common, complex, treatment-resistant & deadliest type of #braincancer (c: National Brain Tumor Society ). TY to the collab of our #FRONTIERstudy investigators helping to advance science against recurrent GBM. bit.ly/3NXKsei
Proud to share John Boockvar, Yafell Serulle, MD, PhD, and Jon Weinstein have begun enrolling patients in Peter Pattison ’s #FRONTIERstudy assessing the use of TheraSphere GBM Y-90 Glass Microsoheres in patients with recurrent #glioblastoma . 🔬🧠
Click the link to learn more: bostonscientific.com/en-US/medical-…
When we talk about advancing science for life at Boston Scientific, this is what we mean. Great to see progress on the #FRONTIERstudy !
An important milestone reached - @RiadSalemIR, Sam Mouli, Roger Stupp & Lurie Cancer Center enrolled initial pts in #FRONTIERstudy , a feasibility study evaluating safety of #TheraSphere GBM Y-90 Glass Microspheres for treatment of #recurrentglioblastoma . bit.ly/3AHaXOK
Proud to see enrollments in the #FRONTIERStudy - a great start to #BrainTumorAwarenessMonth . #RecurrentGBM #iRad
If you missed us at the CSP Physiotherapy UK Conference this year #physio19 , catch up on our research so far with presentations from Nicola Walsh and Dr Hannah Stott now on our website
frontierstudy.co.uk/frontier-news/
New publication from our hosted FRONTIER study frontierstudy.co.uk detailing #realist #evaluation in #healthservices . 👏
Dr. Justin Mausz Makes the #FRONTIERstudy even more exciting. Keep an eye out in Canadian Paramedicine research issue #HintHint Ian Drennan